Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kusuma Kemindo Sentosa Tbk. (KKES) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Kusuma Kemindo Sentosa Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Kusuma Kemindo Sentosa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kusuma Kemindo Sentosa Tbk. trades at Rp74 (market cap 106.5B, 5.74M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Kusuma Kemindo Sentosa Tbk. is more actively traded (5.74M versus 62.5K). Which is the better fit depends on your goals.

KKESOBAT
Market Cap
106.5B164.65B
Volume
5.74M62.5K
Lot
57.43K625
Turnover
420.67M15.03M
Average Price
73.25240.55
Value
420.67M15.03M
Indicative Equilibrium Price
74238
Indicative Equilibrium Volume
6.89K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KKES
View details
OBAT
View details

About Kusuma Kemindo Sentosa Tbk.

PT Kusuma Kemindo Sentosa Tbk (the Company) was established based on Notarial Deed No. 78 dated November 9, 1990 and amended by Deed No. 64 dated September 16, 1991, both were madebefore Notary James Herman Rahardjo, S.H., Notary in Jakarta.

Read more on KKES

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT